Alzheimer's: Common Gene Explains Why Some Drugs Fail
Sumaira FH Published July 22, 2019 | 12:12 PM
New insights into a specific gene variant may help to explain why some Alzheimer's drugs work in certain people but may fail in others
Islamabad (UrduPoint / Pakistan Point News - 22nd July, 2019) New insights into a specific gene variant may help to explain why some Alzheimer's drugs work in certain people but may fail in others.
The findings call for a more personalized approach to drug testing.An individual's genotype may explain why some Alzheimer's drugs work and others fail, new research shows.Earlier this year, a study led by Dr.
Kinga Szigeti, Ph.D., who is the director of the Alzheimer's Disease and Memory Disorders Center at the University of Buffalo, NY, found a key gene that helped explain why some Alzheimer's drugs showed promise in animal models but failed in humans.The gene is called CHRFAM7A, and it is specific to humans, although only 75% of people have it.
It is a so-called fusion gene that is, a fusion between a gene that encodes a receptor for the neurotransmitter acetylcholine, and a type of enzyme called a kinase.Acetylcholine plays a key role in memory and learning, and researchers have long linked it with the development of Alzheimer's.The CHRFAM7A fusion gene encodes the "[alpha]7 nicotinic acetylcholine receptor," but because it only does so in humans, drugs targeting the alpha-7 receptor have proven successful in preclinical, animal models but not in human ones.The previous study by Dr.
Szigeti and her team showed that CHRFAM7A has a modulatory effect on the uptake of the protein beta-amyloid, which is a hallmark of Alzheimer's. However, this previous study was in tissue cultures.In the recent study, Dr.
Szigeti and her team looked at how this gene affects drug effectiveness in humans.The researchers presented their findings at the Alzheimer's Association International Conference, which took place in Los Angeles, CA.Gene explains why some drugs failDr.
Szigeti explains that the CHRFAM7A gene is present in two variants: a functional one and one that is not translated into a protein.
"This splits the population 1-to-3 between non-carriers and carriers," says the researcher.She also explains that 3 out of 4 of the Alzheimer's drugs that are now available target all the acetylcholine receptors.However, drugs that would specifically target the alpha-7 acetylcholine receptor have so far failed in humans."Since this human fusion gene was not present in the animal models and screening systems used to identify drugs, 75% of Alzheimer's patients who do carry this gene are less likely to benefit and therefore are at a disadvantage.""With this study, we compared the effect of cholinesterase inhibitors in patients who did or didn't carry this gene," Dr.
Szigeti says.The team used data from a 10-year-long cohort study carried out by the Texas Alzheimer's Research and Care Consortium, which involved 345 people with Alzheimer's."People who don't have the [CHRFAM7A] gene respond better to the drugs available now," Dr.
Szigeti reports. "Our work confirms that Alpha 7 is a very important target for treating Alzheimer's but the right model a human model has to be used when testing new drugs," she adds.In other words, one drug may work well for 25% of people with Alzheimer's, but fail in the remaining 75%, and vice versa.
This suggests that a more personalized approach is necessary when treating Alzheimer's and screening for potential new drugs.This research provides proof of concept that since different mechanisms are at work in Alzheimer's in different patients, we need to develop more personalized treatments that will prove more effective in individuals."Dr.
Kinga SzigetiThe researchers emphasize the fact that their study is only a proof of concept with its own limitations, and that researchers need to undertake randomized, double-blind trials to confirm the results.
Recent Stories
Mired in crisis, Boeing reports another loss
Session Awarding Ceremony 2024 held at Cadet College Muzaffarabad
Austrian ski great Hirscher to make comeback under Dutch flag
Pakistan, Japan agrees to convene 'Economic Policy Dialogue'
FM Dar conveys deepest sympathy on torrential rains devastation in UAE
Spain PM Sanchez says weighing resignation after wife's graft probe
Tennis: ATP/WTA Madrid Open results - 1st update
Long-lost Klimt portrait auctioned off for 30 mn euros
Osaka seals first win on clay since 2022 in Madrid
Earthquake jolts Karachi
Sindh minister orders operation after attack on police in Ghotki
TikTok to fight US ban law in courts
More Stories From Health
-
Vaccines save at least 154 million lives in 50 years: WHO
12 hours ago -
UHS to issue MBBS degrees within three months after final result
16 hours ago -
Rawalpindi woman gives birth to six babies
6 days ago -
DC calls for intensive anti-polio drive in ICT
7 days ago -
World Hemophilia Day observed to underscore importance of providing comprehensive care
7 days ago -
Six in a family with heart on the 'right side'
7 days ago
-
Diabetic disease increasing rapidly : Dr. Noor Elahi Memon
7 days ago -
World Hemophilia Day observed
8 days ago -
ATC dismisses bail petition of doctor involved in illegal kidneys transplant
15 days ago -
Dr. Shehzad warns against deviation from WHO guidelines on anti-smoking
16 days ago -
Health activists express concerns over attempts to derail tobacco control
18 days ago -
UHS declares MBBS first prof, MS urology exam results
27 days ago